Savitz Ryan's Form 4 filing
Dianthus Therapeutics, Inc. (DNTH) · filed Apr 1, 2026
- Accession no.
- 0001992324-26-000004
- Filed
- Apr 1, 2026
- Trade date
- Mar 31, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $9.49M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Savitz RyanCIK 0001992324 | Officer (EVP, CFO & CBO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | MOption exerciseAcquired | +74,367 | $8.44 | +$627,657.48 | 74,367 | Direct | |
| Mar 31, 2026 | Common Stock | MOption exerciseAcquired | +40,000 | $17.88 | +$715,200 | 114,367 | Direct | |
| Mar 31, 2026 | Common Stock | SSaleDisposed | −1,390 | $78.33 | −$108,878.7 | 112,977 | Direct | |
| Mar 31, 2026 | Common Stock | SSaleDisposed | −21,825 | $78.86 | −$1,721,119.5 | 91,152 | Direct | |
| Mar 31, 2026 | Common Stock | SSaleDisposed | −1,485 | $80.25 | −$119,171.25 | 89,667 | Direct | |
| Mar 31, 2026 | Common Stock | SSaleDisposed | −800 | $81.36 | −$65,088 | 88,867 | Direct | |
| Mar 31, 2026 | Common Stock | SSaleDisposed | −2,366 | $82.84 | −$195,999.44 | 86,501 | Direct | |
| Mar 31, 2026 | Common Stock | SSaleDisposed | −59,800 | $83.90 | −$5,017,220 | 26,701 | Direct | |
| Mar 31, 2026 | Common Stock | SSaleDisposed | −19,469 | $84.57 | −$1,646,493.33 | 7,232 | Direct | |
| Mar 31, 2026 | Common Stock | SSaleDisposed | −7,232 | $85.54 | −$618,625.28 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | MOption exerciseDisposed | −74,367 | $0.00 | $0 | 10,399 | Direct | |
| Mar 31, 2026 | Common Stock | MOption exerciseDisposed | −40,000 | $0.00 | $0 | 80,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.